MARKET

XTNT

XTNT

XTANT MEDICAL
AMEX

Real-time Quotes | Nasdaq Last Sale

2.840
+0.040
+1.43%
After Hours: 2.860 +0.02 +0.70% 19:44 03/05 EST
OPEN
3.070
PREV CLOSE
2.800
HIGH
3.070
LOW
2.440
VOLUME
767.43K
TURNOVER
--
52 WEEK HIGH
6.58
52 WEEK LOW
0.5500
MARKET CAP
221.00M
P/E (TTM)
-5.8221
1D
5D
1M
3M
1Y
5Y
Investors Who Bought Xtant Medical Holdings (NYSEMKT:XTNT) Shares A Year Ago Are Now Up 218%
Unless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...
Simply Wall St. · 4d ago
NIO, C3.ai leads the premarket losers' pack
FibroGen (FGEN) -25% on Q4 earnings release and after FDA to hold AdCom meet to review FibroGen, AstraZeneca's kidney drug.Comstock Mining (LODE) -19% after launching 4M-share public offering.Inseego (INSG) -16% on Q4 earnings release.RedHill Biopharma (RD...
Seekingalpha · 5d ago
Xtant Medical reverses gains after social media-led run on Friday
Xtant Medical Holdings (XTNT) has lost ~13.8% in the premarket today after a ~124.4% gain on Friday when over 60 times the three-month share volume changed hands in a sudden
Seekingalpha · 6d ago
Athenex, Xtant Medical among major healthcare premarket losers' pack
Athenex ATNX -55% on Q4 earnings release and on FDA rejection of oral paclitaxel application in breast cancer.Xtant Medical Holdings (XTNT) -16%.PLx Pharma PLXP -9% after FDA OKs PLx Pharma's Vazalore applications.Lixte Biotechnology Holdings (LIXT) -12%.A...
Seekingalpha · 6d ago
Artificial Bone Material Market Size, Status 2021 by Manufacturers, Type and Application, Forecast to 2027 | Report By Industry Research Experts
Mar 01, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Artificial Bone Material Market”...
The Express Wire · 6d ago
Global Artificial Bone Material Market 2020 Opportunity Assessment, Key Drivers and Challenges, Growth Rate and Forecast to 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- Global Artificial Bone Material Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 aims...
CDN Newswire · 02/28 11:12
BRIEF-Xtant Medical Comments On Trading Activity Of Its Stock
reuters.com · 02/26 21:06
Xtant Medical Comments on Trading Activity of its Stock
BELGRADE, Mont., Feb 26, 2021 (GLOBE NEWSWIRE via COMTEX) -- BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:...
GlobeNewswire · 02/26 21:05
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of XTNT. Analyze the recent business situations of XTANT MEDICAL through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average XTNT stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 14
Institutional Holdings: 11.86M
% Owned: 15.24%
Shares Outstanding: 77.82M
TypeInstitutionsShares
Increased
4
22.60K
New
1
15
Decreased
2
5.68K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.73%
Healthcare Equipment & Supplies
+2.13%
Key Executives
President/Chief Executive Officer/Director
Sean Browne
Chief Financial Officer/Vice President - Finance
Greg Jensen
Chief Operating Officer
Darrel Holmes
Senior Vice President
Kevin Brandt
Chief Scientific Officer
Gregory Juda
Director
John Bakewell
Director
Michael Eggenberg
Director
Robert McNamara
Director
Jeffrey Peters
Director
Matthew Rizzo
No Data
  • All
  • Financials
  • Insiders
More
About XTNT
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Webull offers kinds of Xtant Medical Holdings Inc stock information, including AMEX:XTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTNT stock methods without spending real money on the virtual paper trading platform.